Viewing Study NCT05845268


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-28 @ 9:48 AM
Study NCT ID: NCT05845268
Status: UNKNOWN
Last Update Posted: 2023-05-06
First Post: 2023-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Sponsor: Beijing Friendship Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module